Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.80 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.80 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.80 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | SELP | P16109 | 1/20 | 0.71 |
| ▸ | FAAH | O00519 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | CNR1 | P21554 | 1/20 | 0.68 |
| ▸ | CNR2 | P34972 | 1/20 | 0.68 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.65 |
| ▸ | DGKA | P23743 | 1/20 | 0.63 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.62 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1898251 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL114944 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL12464578 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL16023628 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL18381279 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL24075747 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL3117216 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL22077701 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL22078371 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2734350 | 1.00 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12144817-B2 | Testosterone ester triglyceride formulations | ANTARES PHARMA, INC. (US) | 2024-11-19 | — | — | US | claimed |
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-20250314671-A1 | Diagnostic signature | BCAL Diagnostics Limited (AU) | 2025-10-09 | — | — | US | disclosed |
| US-20250264481-A1 | METHODS FOR PREDICTION AND EARLY DETECTION OF DIABETES | Baker Heart and Diabetes Institute (AU) | 2025-08-21 | — | — | US | disclosed |
| US-12313634-B2 | Methods for prediction and early detection of diabetes | ZORA BIOSCIENCES OY (FI) | 2025-05-27 | — | — | US | disclosed |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | INSTITUTE OF BASIC MEDICAL SCIENCES (CN) | 2025-04-22 | — | — | US | disclosed |
| US-12259389-B2 | Nanoparticles and distinct exosome subsets for detection and treatment of cancer | CORNELL UNIVERSITY (US) | 2025-03-25 | — | — | US | disclosed |
| US-20250041423-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-02-06 | — | — | US | disclosed |
| US-20250032509-A1 | Testosterone Ester Triglyceride Formulations | ANTARES PHARMA, INC. (US) | 2025-01-30 | — | — | US | disclosed |
| EP-4333801-A1 | NASAL SLEEP FORMULATION | CS Medica A/S (DK) | 2024-03-13 | — | — | EP | disclosed |
| CN-117377462-A | Nasal sleeping preparation | 融实医药(海南)有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230266329-A1 | NANOPARTICLES AND DISTINCT EXOSOME SUBSETS FOR DETECTION AND TREATMENT OF CANCER | UNIV CORNELL (US) | 2023-08-24 | — | — | US | disclosed |
| CN-116165299-A | Method for distinguishing Pleurotus ostreatus from Pleurotus ostreatus by using lipid | 中南民族大学 | 2023-05-26 | — | — | CN | disclosed |
| WO-2022233833-A1 | NASAL SLEEP FORMULATION | CS MEDICA A/S (DK) | 2022-11-10 | — | — | WO | disclosed |
| CN-115266953-A | Biomarker combination for bone tuberculosis diagnosis and application thereof | 首都医科大学附属北京胸科医院 | 2022-11-01 | — | — | CN | disclosed |
| WO-2022101442-A1 | BIOMARKERS FOR SEVERE PULMONARY CONDITION | ZORA BIOSCIENCES OY (FI) | 2022-05-19 | — | — | WO | disclosed |
| CN-114324653-A | Identification method of peanut variety | 广东省农业科学院作物研究所 | 2022-04-12 | — | — | CN | disclosed |
| US-20220079955-A1 | Testosterone Ester Triglyceride Formulations | ANTARES PHARMA, INC. (US) | 2022-03-17 | — | — | US | disclosed |
| US-8828412-B2 | Stable polyphenol containing ophthalmic emulsion for treating dry eyes | Abbott Medical Optics Inc. (US) | 2014-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | FABP2, NSUN2, TRDMT1 | PRKCA 1593/4885PRKCE 3068/4885PRKCQ 2159/4885 |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | PRKCA 2378/4885PRKCE 3922/4885PRKCQ 3379/4885 |
| US-20220079955-A1 | Testosterone Ester Triglyceride Formulations | SHBG, NR5A1, HSD17B11 | PRKCA 2276/4885PRKCE 1974/4885PRKCQ 2449/4885 |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | CHMP4B, FIP1L1, LIPC | PRKCA 55/4885PRKCE 194/4885PRKCQ 343/4885 |
| US-20250032509-A1 | Testosterone Ester Triglyceride Formulations | SHBG, NR5A1, HSD17B11 | PRKCA 2276/4885PRKCE 1974/4885PRKCQ 2449/4885 |
| US-20250041423-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | CHMP4B, EXOSC5, FIP1L1 | PRKCA 164/4885PRKCE 846/4885PRKCQ 902/4885 |
| US-12144817-B2 | Testosterone ester triglyceride formulations | SHBG, NR5A1, HSD17B11 | PRKCA 2276/4885PRKCE 1974/4885PRKCQ 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.